Link Between Gout and Cardiovascular Events – An Interview With Robert Keenan, MD
Based on recent study findings, Robert Keenan, MD, discusses the risk for cardiovascular events among patients with gout.
Gout
Krystexxa Plus Methotrexate Approved for Uncontrolled Gout
The expanded approval was based on data from the phase 4 MIRROR trial, which evaluated Krystexxa plus methotrexate in 152 adults with uncontrolled gout.
Pegloticase Plus Methotrexate Gets Priority Review for Uncontrolled Gout
The sBLA submission is supported by data from the phase 4 MIRROR trial.
Four Diets Linked to Gout Prevention in Women
Four healthy diets were linked to a reduced risk for new-onset gout in women. Diet selection can be made based on patient preference and comorbidities.
No Improvement in Bone Erosion Scores with Intensive Oral ULT for Erosive Gout
Researchers evaluated the effect of intensive serum urate-lowering therapy on bone erosion scores in erosive gout.
Horizon Seeks Approval of Pegloticase Plus Methotrexate for Uncontrolled Gout
The sBLA submission is supported by data from the phase 4 MIRROR trial.
Urate-Degrading Enzyme Fast Tracked for Hyperuricemia With Gout and CKD
ALLN-346 is an investigational, first-in-class, nonabsorbed, orally-administered enzyme that breaks down urate in the gastrointestinal tract.
Pain Management in Gout – A Video Interview With Lawrence Edwards, MD
In light of Pain Awareness and Arthritis Awareness Month, Lawrence Edwards, MD, discusses the importance of addressing pain in patients with gout and the role of collaboration between clinical specialties during the management of painful gout flares.
Metagenomic Analysis Shows That the Gut Microbiome May Have a Role in Gout
Researchers of a metagenomic analysis assessed the taxonomic and functional signatures of the gut microbiome in gout and its association with clinical parameters and response to therapeutic interventions.
Novel Risk Stratification Tool Identifies Patients at High Risk for Inpatient Gout Flare
Researchers developed and validated a gout flare risk stratification tool for patients with gout who were hospitalized for nongout conditions.
- Loading...
Loading...
Loading... 
Loading...